Vaxine Pty Ltd is a rapidly growing Australian biotechnology company based in Adelaide that has developed an impressive pipeline of vaccines against infectious disease, allergy, and cancer . Vaxine has developed the Advax range of proprietary polysaccharide adjuvants and is currently applying this state of the art adjuvant technology to development of vaccines against hepatitis B, pandemic influenza, Japanese encephalitis, West Nile virus, malaria, HIV and rabies, amongst others.
View Top Employees from Vaxine Pty LtdWebsite | http://vaxine.net |
Revenue | $6 million |
Employees | 18 (18 on RocketReach) |
Founded | 2002 |
Address | 1 Flinders Dr, Bedford Park, South Australia 5042, AU |
Phone | +61 8 8204 4572 |
Technologies |
JavaScript,
HTML,
PHP
+18 more
(view full list)
|
Industry | Biotechnology Research, Chemicals, Petrochemicals, Glass & Gases, Biotechnology, Manufacturing, Science and Engineering |
Web Rank | 15 Million |
Keywords | Vaxine Pty Ltd, Vaxine Ltd, Vaxine |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325414 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Vaxine Pty Ltd employee's phone or email?
The Vaxine Pty Ltd annual revenue was $6 million in 2024.
18 people are employed at Vaxine Pty Ltd.
Vaxine Pty Ltd is based in Bedford Park, South Australia.
The NAICS codes for Vaxine Pty Ltd are [325414, 32, 3254, 325, 32541].
The SIC codes for Vaxine Pty Ltd are [28, 283].